Aditxt Inc. Proposes Corporate Name Change to bitXbio as Part of Blockchain Integration Strategy

Aditxt Inc. (NASDAQ: ADTX) has detailed its bitXbio strategy, a framework designed to connect public markets, blockchain and Web3 technologies, and digital asset treasuries to support breakthrough health innovations through a participation-driven model. The company filed a Preliminary Proxy Statement seeking shareholder approval for several key proposals, including an Employee Stock Purchase Plan and a non-binding advisory vote to amend its Certificate of Incorporation to change its corporate name to bitXbio, Inc. This proposed name change reflects the company's planned evolution into a platform that links digital assets with life sciences ventures, marking a significant strategic shift in its operational focus.

The bitXbio strategy represents a novel approach to healthcare innovation funding and development, leveraging emerging technologies to create new pathways for supporting promising medical advancements. By integrating blockchain and Web3 technologies into its core operations, Aditxt aims to democratize innovation in the health sector while ensuring that every stakeholder's voice is heard and valued within its ecosystem. The company currently operates four distinct programs focused on autoimmunity, cancer and early disease detection, infectious diseases, and women's health, all of which would benefit from this new strategic direction.

The Employee Stock Purchase Plan included in the proxy statement is intended to strengthen employee-shareholder alignment and support the company's long-term growth vision. This initiative demonstrates Aditxt's commitment to creating a collaborative environment where employees have a direct stake in the company's success. The full details of these proposals and the strategic rationale behind them are available in the company's official documentation at https://ibn.fm/5CjtY. Investors seeking additional information about Aditxt's developments can access the company's newsroom at https://ibn.fm/ADTX, which provides comprehensive updates on corporate activities and strategic initiatives.

This strategic pivot toward blockchain integration and digital asset management in the healthcare sector represents a broader trend of traditional life sciences companies embracing emerging technologies to enhance innovation and stakeholder engagement. The proposed transformation into bitXbio, Inc. signals Aditxt's ambition to position itself at the intersection of digital innovation and healthcare advancement, potentially creating new models for funding and developing medical breakthroughs. The shareholder vote on these proposals will determine whether the company proceeds with this significant rebranding and strategic realignment, which could have far-reaching implications for how healthcare innovations are funded and developed in the digital age.